COCP Cocrystal Pharma, Inc.

BEARISH Impact: 7/10 EFFECT
Horizon days Filed May 4, 2026 Processed 1mo ago SEC 9999999995-26-001445
IPO/offering going effective
Latest settled — T+20d
COCP ▼ -15.27% at T+20d
SHORT call ✓ call won +15.27% · α vs SPY +20.91% · entry $1.31 → $1.11
Next anchor: T+60d in 6w
Last close $0.9900 (close Jun 12) · +24.43% from $1.31 entry (call sign-flipped)
Entry anchored
May 4, 2026
via day open
T+1d
+5.34%
call -5.34% · α -4.55%
$1.38
settled 6w ago
T+5d
-0.76%
call +0.76% · α +3.70%
$1.30
settled 5w ago
T+20d
-15.27%
call +15.27% · α +20.91%
$1.11
settled 13d ago
T+60d
call — · α —
in 6w

Price Chart

Loading chart...

Executive Summary

Cocrystal Pharma's $150M shelf registration (S-3) became effective on May 1, 2026, allowing the company to offer securities from time to time. With a market cap of only ~$19M, this represents extreme potential dilution, creating a significant overhang on the stock.

Actionable Insight

Watch for any takedown notice, prospectus supplement, or ATM program announcement. The steep dilution overhang may pressure the stock in the near term; any offering details will clarify the immediate impact.

Key Facts

  • Shelf registration effective May 1, 2026 (File No. 333-295279).
  • Offering size up to $150,000,000 in common stock, preferred stock, warrants, or units.
  • Company market cap is approximately $19 million.
  • Proceeds could be used for any corporate purpose, but specifics are not disclosed.

Financial Impact

Up to $150 million in securities can be sold, exceeding the current market cap by ~7.9x, implying massive potential dilution.

dilutionmarket cap

Risk Factors

  • Substantial dilution to existing shareholders if the shelf is utilized.
  • Stock price may decline as market prices in potential future offerings.
  • Lack of clarity on use of proceeds increases uncertainty.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
88% bullish (8 analysts)

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-001445
Document: 9999999995-26-001445-index.html9999999995-26-001445
Document: 9999999995-26-001445.txt9999999995-26-001445
8 reports for COCP
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for COCP — sortable, filterable
Type Now
Jun 9, 2026
5d ago
8-K
NEUTRAL ★ 2/10
$1.02 awaiting T+1awaiting T+1$0.9900 (−2.46%)
Jun 3, 2026
11d ago
8-K
NEUTRAL ★ 4/10
$1.06 $1.05▼ −0.94%▼ −1.34%$0.9900 (−6.60%)
May 27, 2026
18d ago
DEFA14A
NEUTRAL ★ 2/10
$1.13 $1.12▼ −0.89%▼ −1.12%$0.9900 (−12.39%)
May 26, 2026
19d ago
8-K
BULLISH ★ 6/10
$1.13 $1.12▼ −0.89%▼ −0.90%$0.9900 (−12.39%)
May 15, 2026
4w ago
Press Release
NEUTRAL ★ 5/10
$1.20 $1.18▼ −1.67%▼ −1.60%$0.9900 (−17.50%)
May 4, 2026
6w ago
EFFECT
BEARISH ★ 7/10
$1.31 $1.38▼ −5.34%▼ −4.55%$0.9900 (+24.43%)
Apr 2, 2026
10w ago
8-K
BULLISH ★ 7/10
$1.51 $1.50▼ −0.66%▼ −1.14%$0.9900 (−34.44%)
Mar 31, 2026
10w ago
8-K
MIXED ★ 6/10
$1.01 $1.02▲ +0.99%▲ +0.24%$0.9900 (−1.98%)
Showing 8 of 8

US Market Status

Market Closed — Opens in 4h 5m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access